Literature DB >> 2553692

Generation of Lys-gamma 3-melanotropin from pro-opiomelanocortin 1-77 by a bovine intermediate lobe secretory vesicle membrane-associated aspartic protease and purified pro-opiomelanocortin converting enzyme.

F E Estivariz1, N P Birch, Y P Loh.   

Abstract

The ability of bovine intermediate lobe secretory vesicle membrane-associated enzyme(s) and purified, soluble paired basic residue-specific, pro-opiomelanocortin converting enzyme (Loh, Y.P., Parish, D. C., and Tuteja, R. (1985) J. Biol. Chem. 260, 7194-7205) to cleave bovine NH2-terminal pro-opiomelanocortin1-77 (N-POMC 1-77) was investigated. Purified pro-opiomelanocortin converting enzyme and an enzyme activity associated with the secretory vesicle membrane were shown to cleave bovine N-POMC1-77 to two major products: N-POMC1-49 and Lys-gamma 3-melanotropin (MSH), and one minor product, gamma 3-MSH. These products were identified by their retention times on high performance liquid chromatography, immunological characteristics, and for Lys-gamma 3-MSH, amino acid composition. The products generated indicate cleavage preferentially between Arg 49-Lys 50 of bN-POMC1-77 (where b indicates bovine), which is identical to the processing pattern found in the bovine intermediate lobe in situ. The membrane converting activity was shown to be stimulated by 5 mM Ca2+ and has a pH optimum of 4-5 and an inhibitor profile characteristic of an aspartic protease. This suggests that the membrane-associated enzyme involved is very similar or identical to the purified, soluble pro-opiomelanocortin converting enzyme, which has previously been reported to be an acidic, aspartic protease responsible for the initial steps of POMC processing. The results of this study lead to the proposal that the lack of processing of the Arg49-Lys50 site in POMC in the anterior lobe versus the intermediate lobe of the pituitary in vivo may be due to other regulatory mechanisms rather than invoking the existence in the intermediate lobe of another enzyme specific for this site, different from pro-opiomelanocortin converting enzyme.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553692

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  5 in total

Review 1.  Intracellular trafficking and processing of pro-opiomelanocortin.

Authors:  Y P Loh; K I Andreasson; N P Birch
Journal:  Cell Biophys       Date:  1991 Oct-Dec

Review 2.  The Jeremiah Metzger Lecture. From POMC to functional diversity of neural peptides: the key importance of convertases.

Authors:  M Chretien; L Gasper; S Benjannet; M Mbikay; C Lazure; N G Seidah
Journal:  Trans Am Clin Climatol Assoc       Date:  1991

3.  Bilateral adrenal enucleation-induced changes in adenohypophyseal pro-opiomelanocortin (POMC)-related peptides synthesis and secretion: a comparative study with adrenalectomized rats.

Authors:  M J Perone; A N Chisari; C L Gómez Dumm; E Spinedi; F E Estivariz
Journal:  J Endocrinol Invest       Date:  1997-04       Impact factor: 4.256

4.  Shared functions in vivo of a glycosyl-phosphatidylinositol-linked aspartyl protease, Mkc7, and the proprotein processing protease Kex2 in yeast.

Authors:  H Komano; R S Fuller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-11-07       Impact factor: 11.205

Review 5.  Identification of a sorting signal for the regulated secretory pathway at the N-terminus of pro-opiomelanocortin.

Authors:  D R Cool; Y P Loh
Journal:  Biochimie       Date:  1994       Impact factor: 4.079

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.